Drug Type Oligonucleotide |
Synonyms Immune diseases therapy (Sanegene bio) |
Target- |
Action- |
Mechanism RNA interference |
Therapeutic Areas |
Active Indication- |
Inactive Indication |
Originator Organization |
Active Organization- |
Inactive Organization |
License Organization- |
Drug Highest PhaseDiscontinuedIND Application |
First Approval Date- |
Regulation- |

| Indication | Highest Phase | Country/Location | Organization | Date |
|---|---|---|---|---|
| Immune System Diseases | IND Application | China | 04 Sep 2024 |





